BRIEF-Conmed Corp - Announces Exit From Gastroenterology Product Lines

CONMED Corporation +1.48%

CONMED Corporation

CNMD

40.39

+1.48%

- Conmed Corp CNMD.N:

  • CONMED CORP - ANNOUNCES EXIT FROM GASTROENTEROLOGY PRODUCT LINES

  • CONMED CORP - COMPANY EXPECTS EPS DILUTION OF $0.45-$0.55 IN 2026

  • CONMED CORP - REAFFIRMS 2025 REVENUE AND EPS GUIDANCE

  • CONMED CORP: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED

Source text: ID:nBw9vdjPna

Further company coverage: CNMD.N


((Reuters.Briefs@thomsonreuters.com;))

سيتم الرد على كل الأسئلة التي سألتها
امسح رمز الاستجابة السريعة للاتصال بنا
whatsapp
يمكنك التواصل معنا أيضا من خلال